Surveillance of community antimicrobial use in resource-constrained settings - experience from five pilot projects

Tropical Medicine and International Health

Volumn 16, Issue 2, 2011, Pages 152-161

  Holloway, Kathleen ^a   Mathai, Elisabeth ^b   Gray, Andy ^c  

^a WHO Regional Office for South East Asia ^*  (India)

^b Patient Safety Programme   (Switzerland)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Antibiotics; Antimicrobial resistance; Community; Developing countries; Drug use; Surveillance

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN; COTRIMOXAZOLE; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; COMMUNITY RESOURCE MANAGEMENT; COMPARATIVE STUDY; DEVELOPING WORLD; FIELD SURVEY; HEALTH SERVICES; WORLD HEALTH ORGANIZATION;

ANTIBIOTIC RESISTANCE; ARTICLE; COMMUNITY CARE; COMPARATIVE STUDY; DRUG ABUSE; DRUG SURVEILLANCE PROGRAM; DRUG USE; FEASIBILITY STUDY; HEALTH CARE PLANNING; HUMAN; INDIA; MAJOR CLINICAL STUDY; PILOT STUDY; PRESCRIPTION; SOUTH AFRICA;

ANTI-BACTERIAL AGENTS; DEVELOPING COUNTRIES; DRUG PRESCRIPTIONS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; EPIDEMIOLOGIC METHODS; HUMANS; INDIA; MEDICALLY UNDERSERVED AREA; SEASONS; SOUTH AFRICA;

INDIA; SOUTH AFRICA;

EID: 78651423303     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02695.x     Document Type: Article

References (22)

1. Ansari F, Erntell M, Goossens H & Davey P (2009) The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clinical Infectious Diseases 49, 1496-1504.
2. Bronzwaer SL, Cars O, Buchholz U et al. (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerging Infectious Diseases 8, 278-282.
3. Chaudhury RR, Parameswar R, Gupta U, Sharma S, Tekur U & Bapna JS (2005) Quality medicines for the poor: experience of the Delhi programme on rational use of drugs. Health Policy and Planning 20, 124-136.
4. Directorate, Department of Health (2003) Access to Affordable Medicines, Impact of the Essential Drugs Programme at Primary Health Care Level in South Africa: Key findings and Recommendations of Surveys in 2003. Department of Health, Pretoria, South Africa.
5. Fairall LR, Zwarenstein M & Bateman ED et al. (2005) Effect of educational outreach to nurses on tuberculosis case detection and primary care of respiratory illness: pragmatic cluster randomised controlled trial. BMJ 331, 750-754.
6. Hardon A, Hodgkin C & Fresle D, eds (2004) How to Investigate the Use of Medicines by Consumers. World Health Organization and University of Amsterdam, Geneva.
7. Haupt SG, Truter I, Milne PJ & Graz M (2002) Prescription of third-generation cephalosporins for upper respiratory tract infections in the Port Elizabeth area. South African Medical Journal 92, 274-275.
8. Holloway KA, Mathai E & Sorensen T et al., eds (2009) Community-based Surveillance of Antimicrobial Use and Resistance in Resource-constrained Settings. Report on Five Pilot Projects (WHO/EMP/MAR/2009.2). World Health Organization, Geneva.
9. Indira KKS, Chandy SJ, Jeyaseelan L, Kumar R & Suresh S (2008) Antimicrobial prescription patterns for common acute infections in some rural and urban health facilities of India. Indian Journal of Medical Research 128, 165-171.
10. Karande S, Sankhe P & Kulkarni M (2005) Patterns of prescription and drug dispensing. Indian Journal of Pediatrics 72, 117-121.
11. Katende-Kyenda NL, Lubbe MS, Serfontein JH & Truter I (2006) Inappropriateness of antimicrobial prescription in private primary health care settings in South Africa. South African Medical Journal 96, 704-705.
12. Mhetre NA, Bodhankar SL, Pandit VA & Zambare GN (2003) "Study of the pattern of drug usage in an urban area". Indian Journal of Pharmacology 35, 316-317.
13. Muller A, Coenen S, Monnet DL, Goossens H & ESAC project group (2007) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005. Eurosurveillance Weekly 12, E071011.1.
14. Rishi RK, Sangeeta S, Surendra K & Tailang M (2003) Prescription audit: experience in Garhwal (Uttaranchal), India. Tropical Doctor 33, 76-79.
15. Summers RS, Moller H, Thupana M, Nobela C & Hlongwane E (1997) Evaluation of the Transformation of Pharmaceutical and Related Services in the Northern Province. Medicos Pharmacy Project and MEDUNSA School of Pharmacy for the Northern Province Department of Health, Pretoria, South Africa.
16. WHO (2004) The World Medicines Situation (Chapter 8 on Rational Use of Medicines); WHO/EDM/PAR/2004.5. World Health Organisation, Geneva.
17. WHO (2005) Containing Antimicrobial Resistance; Policy Perspectives on Medicines no.10. (WHO/PSM/2005.1). World Health Organisation, Geneva.
18. WHO (2009) Medicines Use in Primary Care in Developing and Transitional Countries: Fact Book Summarising Results From Studies Reported Between 1990 and 2006 (WHO/EMP/MAR/2009.3). World Health Organisation, Geneva.
19. World Health Assembly (2005) Improving the Containment of Antimicrobial Resistance. WHA58.27. World Health Organization, Geneva.
20. World Health Organisation (2001) Global Strategy for Containment of Antimicrobial Resistance World Health Organisation, Geneva.
21. World Health Organization (1993) How to Investigate Drug Use in Health Facilities. World Health Organization, Geneva.
22. World Health Organization (2008) Collaborating Centre for Drug Statistics Methodology, ATC/DDD Index. World Health Organization Collaborating Centre for Drug Statistics Methodology, Oslo. Available at: .